يعرض 1 - 10 نتائج من 34 نتيجة بحث عن '"Erick Morris"', وقت الاستعلام: 1.17s تنقيح النتائج
  1. 1
    دورية أكاديمية
    BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics

    المؤلفون: Rongqing Aaron Pan, Youzhen Wang, Shumei Qiu, Mariana Villalobos-Ortiz, Jeremy Ryan, Erick Morris, Ensar Halilovic, Anthony Letai

    المصدر: Haematologica, Vol 109, Iss 4 (2023)

    مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

    وصف الملف: electronic resource

    العلاقة: https://haematologica.org/article/view/11319Test; https://doaj.org/toc/0390-6078Test; https://doaj.org/toc/1592-8721Test

    الوصول الحر: https://doaj.org/article/ef99a7b0fb06433084a5acc8647bfe60Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics.

    المؤلفون: Pan, Rongqing, Wang, Youzhen, Qiu, Shumei, Villalobos-Ortiz, Mariana, Ryan, Jeremy, Erick, Morris, Halilovic, Ensar, Letai, Anthony

    العلاقة: Pan, Rongqing, Wang, Youzhen, Qiu, Shumei, Villalobos-Ortiz, Mariana, Ryan, Jeremy, Erick, Morris, Halilovic, Ensar and Letai, Anthony (2024) BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics. Haematologica, 109 (4). pp. 1253-1258. ISSN 1592-8721

    الإتاحة: https://doi.org/10.3324/haematol.2023.283060Test
    https://oak.novartis.com/48272Test/
    https://haematologica.org/article/view/haematol.2023.283060Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Supplementary Figures S1-S15 from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

    المؤلفون: Joseph Lehár, Giordano Caponigro, Levi A. Garraway, Ensar Halilovic, Joel Greshock, Sébastien Jeay, Jens Wuerthner, Erick Morris, Dale Porter, Robert Schlegel, William R. Sellers, Matthew Zubrowski, Ali Farsidjani, Fred Harbinski, Samuel Ho, Angela Tam, Nicolas Ebel, Stéphane Ferretti, Thomas Horn

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98cb2d6505e4155b2e688283a12221a3Test
    https://doi.org/10.1158/0008-5472.22412681.v1Test


    أضف إلى المفضلة
  4. 4
    Supplementary Table S6 from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

    المؤلفون: Joseph Lehár, Giordano Caponigro, Levi A. Garraway, Ensar Halilovic, Joel Greshock, Sébastien Jeay, Jens Wuerthner, Erick Morris, Dale Porter, Robert Schlegel, William R. Sellers, Matthew Zubrowski, Ali Farsidjani, Fred Harbinski, Samuel Ho, Angela Tam, Nicolas Ebel, Stéphane Ferretti, Thomas Horn

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b9cb74108a6b00f8a010cd7554ba8d8Test
    https://doi.org/10.1158/0008-5472.22412660.v1Test


    أضف إلى المفضلة
  5. 5
    Supplementary Data from Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

    المؤلفون: Scott Antonia, Luigi Manenti, Felipe K. Hurtado, Mehreteab Aregay, Erick Morris, Liza Morgan, Julio Castro, Theresa A. Boyle, Amer A. Beg, Dung Tsa Chen, Zhihua Chen, Margaret L. Barlow, Ram Thapa, Eric B. Haura, Jhanelle E. Gray, Tawee Tanvetyanon, Ben Creelan, Alberto A. Chiappori

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132a17999cf561e16d852c6c6bd2e740Test
    https://doi.org/10.1158/1078-0432.22482872Test


    أضف إلى المفضلة
  6. 6
    Supplementary Methods and References from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

    المؤلفون: Joseph Lehár, Giordano Caponigro, Levi A. Garraway, Ensar Halilovic, Joel Greshock, Sébastien Jeay, Jens Wuerthner, Erick Morris, Dale Porter, Robert Schlegel, William R. Sellers, Matthew Zubrowski, Ali Farsidjani, Fred Harbinski, Samuel Ho, Angela Tam, Nicolas Ebel, Stéphane Ferretti, Thomas Horn

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b4fd986a1adc400835e1b3e889985c8Test
    https://doi.org/10.1158/0008-5472.22412678Test


    أضف إلى المفضلة
  7. 7
    Data from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

    المؤلفون: Joseph Lehár, Giordano Caponigro, Levi A. Garraway, Ensar Halilovic, Joel Greshock, Sébastien Jeay, Jens Wuerthner, Erick Morris, Dale Porter, Robert Schlegel, William R. Sellers, Matthew Zubrowski, Ali Farsidjani, Fred Harbinski, Samuel Ho, Angela Tam, Nicolas Ebel, Stéphane Ferretti, Thomas Horn

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f02f59d0526280bdfcd780334cd0b86aTest
    https://doi.org/10.1158/0008-5472.c.6508490.v1Test


    أضف إلى المفضلة
  8. 8
    Supplementary Figure from Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

    المؤلفون: Scott Antonia, Luigi Manenti, Felipe K. Hurtado, Mehreteab Aregay, Erick Morris, Liza Morgan, Julio Castro, Theresa A. Boyle, Amer A. Beg, Dung Tsa Chen, Zhihua Chen, Margaret L. Barlow, Ram Thapa, Eric B. Haura, Jhanelle E. Gray, Tawee Tanvetyanon, Ben Creelan, Alberto A. Chiappori

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5cd0e8a30096fe605803c93a7c6ea5Test
    https://doi.org/10.1158/1078-0432.22482863.v1Test


    أضف إلى المفضلة
  9. 9
    Supplementary Table and Figure Legends from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

    المؤلفون: Joseph Lehár, Giordano Caponigro, Levi A. Garraway, Ensar Halilovic, Joel Greshock, Sébastien Jeay, Jens Wuerthner, Erick Morris, Dale Porter, Robert Schlegel, William R. Sellers, Matthew Zubrowski, Ali Farsidjani, Fred Harbinski, Samuel Ho, Angela Tam, Nicolas Ebel, Stéphane Ferretti, Thomas Horn

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a1be4434e204955054576eb7832758Test
    https://doi.org/10.1158/0008-5472.22412657Test


    أضف إلى المفضلة
  10. 10
    Data from Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

    المؤلفون: Scott Antonia, Luigi Manenti, Felipe K. Hurtado, Mehreteab Aregay, Erick Morris, Liza Morgan, Julio Castro, Theresa A. Boyle, Amer A. Beg, Dung Tsa Chen, Zhihua Chen, Margaret L. Barlow, Ram Thapa, Eric B. Haura, Jhanelle E. Gray, Tawee Tanvetyanon, Ben Creelan, Alberto A. Chiappori

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c600f5561f5796c03303f29e1f1e770Test
    https://doi.org/10.1158/1078-0432.c.6531020Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث